Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Redoxon Orangenaroma" (30)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Ascorbic Acid (Vit C) (A11GA01) 17 products
WHO-DDD
DrugBank.ca
IP
CI
Cegrovit
10
PR
6.50
k.A.
Effervescent tablets: Acidum Ascorbicum 1 g
HELP Pharma
Switzerland AG
D
FB
G
IP
CI
Redoxon orange 1g
30 Tablet(s)
PR
PR
k.A.
Effervescent tablets: Acidum Ascorbicum 1 g
Bayer (Schweiz) AG
D
FB
G
IP
Vitamin C Streuli 10 %/ 5 mL
10 ampoule(s)
PR
PR
k.A.
Injection solution: Acidum Ascorbicum 500mg / 5ml
Streuli Pharma AG
B
FB
G
IP
Vitamin C Streuli 20 %/ 5 mL
10 ampoule(s)
PR
PR
k.A.
Injection solution: Acidum Ascorbicum 1000mg / 5ml
Streuli Pharma AG
B
FB
G
IP
CI
Burgerstein Vitamin C
retard
30
PR
PR
k.A.
Capsules: Acidum Ascorbicum 500 mg
Antistress
Aktiengesellschaft für
Gesundheitsschutz
D
FB
G
IP
CI
Burgerstein Vitamin C
retard
100
PR
PR
k.A.
Capsules: Acidum Ascorbicum 500 mg
Antistress
Aktiengesellschaft für
Gesundheitsschutz
D
FB
G
IP
CI
Redoxon Orangenaroma
60 Tablet(s)
PR
PR
k.A.
Kautabletten zuckerfrei: Acidum Ascorbicum 500 mg
Bayer (Schweiz) AG
D
FB
G
Actilife Vitamin C 150 mg
Acerola
20 Brausetabletten
PR
PR
k.A.
Effervescent tablets: 2 Active Agents
Migros-
Genossenschafts-Bund
E
FB
G
Actilife Vitamin C 150 mg
Acerola
20 Brausetabletten
PR
PR
k.A.
Effervescent tablets: 2 Active Agents
Migros-
Genossenschafts-Bund
E
FB
G
Actilife Vitamin C 150 mg
Acerola
20 Brausetabletten
PR
PR
k.A.
Effervescent tablets: 2 Active Agents
Migros-
Genossenschafts-Bund
E
FB
G
Taxofit Vitamin C
20 Brausetabletten
PR
PR
k.A.
Effervescent tablets: Acidum Ascorbicum 500 mg
Melisana AG
D
FB
G
CI
Vicemex
10 Brausetabletten
PR
PR
k.A.
Effervescent tablets: Acidum Ascorbicum 1 g
Acino Pharma AG
D
FB
G
CI
Viforcit
10 Brausetabletten
PR
PR
k.A.
Effervescent tablets: Acidum Ascorbicum 1 g
Vifor (International) AG
D
FB
G
Taxofit Vitamin C
20 Kautabletten
PR
PR
k.A.
Chewing tablets: Acidum Ascorbicum 500 mg
Melisana AG
D
FB
G
Vitamin C UPSA
30 Kautabletten
PR
PR
k.A.
Chewing tablets: 2 Active Agents
Upsamedica GmbH
D
FB
G
Vitamin C UPSA
30 Kautabletten
PR
PR
k.A.
Chewing tablets: 2 Active Agents
Upsamedica GmbH
D
FB
G
C-Naryl
90 Tablet(s)
PR
16.00
k.A.
Tablets: Acidum Ascorbicum 500 mg
Laboratoire Dr. E.
Homberger SA
D
FB
G
(Codice) 13 products
IP
CI
Ebvallo
PR
PR
k.A.
Pierre Fabre Pharma SA
A
FB
G
IP
CI
Imodium
‐
I
-
T
20 Capsule(s)
3.87
6.85
20 %
Capsules: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
D / SL / SO
FB
G
IP
CI
Imodium
-
T
60 Capsule(s)
9.40
26.60
20 %
Capsules: Loperamidi Hydrochloridum 2 mg
JNTL Consumer Health II
(Switzerland) GmbH
B / SL / SO
FB
G
L
IP
Vegzelma 100 mg/4 ml
257.57
296.55
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Vegzelma 400 mg/16 ml
962.84
1063.55
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1484.04
1630.40
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Ogivri 150 mg
456.84
513.25
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Medius AG
A / SL
FB
G
IP
CI
Bilaxten 6 mg / ml
5 ml
PR
PR
k.A.
Eye drops: Bilastinum 6 mg/ml
A. Menarini GmbH
B
FB
G
IP
CI
Regaine 2 %
60 ml
PR
PR
k.A.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Regaine 2 %
3 x 60 ml
PR
PR
k.A.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Regaine 5 %
60 ml
PR
PR
k.A.
Solution: Minoxidilum 50 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Regaine 5 %
3 x 60 ml
PR
PR
k.A.
Solution: Minoxidilum 50 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
Mylotarg 5 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home